Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Syncor Xigris Delivery For Lilly Is First Non-Radiopharmacy Agreement

Executive Summary

Syncor's agreement to provide emergency delivery of Lilly's pending sepsis agent Xigris (drotrecogin alfa) is the company's first distribution deal outside of radiopharmacy.
Advertisement

Related Content

Cardinal To Run Xigris Emergency Distribution Via Acquisition Of Syncor
Cardinal To Run Xigris Emergency Distribution Via Acquisition Of Syncor
Idec Zevalin NHL Indication Split By Accelerated/Standard Approval
Idec Zevalin NHL Indication Split By Accelerated/Standard Approval
Xigris Inventory Strategy At Ochsner: 1.5 Doses Will Be Kept In Stock
Xigris Inventory Strategy At Ochsner: 1.5 Doses Will Be Kept In Stock
APACHE II Sepsis Score Best Indicator Of Xigris Benefit, Labeling States
APACHE II Sepsis Score Best Indicator Of Xigris Benefit, Labeling States
Lilly Xigris Price: Purchasers Appear Ready For Up To $5,000 Per Dose
Advertisement
UsernamePublicRestriction

Register

PS038422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel